These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 23383670)

  • 21. Interplay between neuroimmunoendocrine systems during post-traumatic stress disorder: a minireview.
    Bauer ME; Wieck A; Lopes RP; Teixeira AL; Grassi-Oliveira R
    Neuroimmunomodulation; 2010; 17(3):192-5. PubMed ID: 20134200
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Post-traumatic stress disorder and substance use disorder: epidemiology, nature and neurobiology].
    Martínez-Raga J; Didia-Attas J; Ruiz M; Knecht CC; Cepeda S; San Molina L; Pérez-Gálvez B
    Vertex; 2005; 16(63):325-31. PubMed ID: 16220147
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Status of glucocorticoid alterations in post-traumatic stress disorder.
    Yehuda R
    Ann N Y Acad Sci; 2009 Oct; 1179():56-69. PubMed ID: 19906232
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Psychosocial animal model of PTSD produces a long-lasting traumatic memory, an increase in general anxiety and PTSD-like glucocorticoid abnormalities.
    Zoladz PR; Fleshner M; Diamond DM
    Psychoneuroendocrinology; 2012 Sep; 37(9):1531-45. PubMed ID: 22421563
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Post-traumatic stress disorder (PTSD): the syndrome with multiple faces].
    Waddington A; Ampelas JF; Mauriac F; Bronchard M; Zeltner L; Mallat V
    Encephale; 2003; 29(1):20-7. PubMed ID: 12640323
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuroendocrine response to CRF stimulation in veterans with and without PTSD in consideration of war zone era.
    Golier JA; Caramanica K; Yehuda R
    Psychoneuroendocrinology; 2012 Mar; 37(3):350-7. PubMed ID: 21813244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HPA- and HPT-axis alterations in chronic posttraumatic stress disorder.
    Olff M; Güzelcan Y; de Vries GJ; Assies J; Gersons BP
    Psychoneuroendocrinology; 2006 Nov; 31(10):1220-30. PubMed ID: 17081699
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Posttraumatic stress disorder.
    Jorge RE
    Continuum (Minneap Minn); 2015 Jun; 21(3 Behavioral Neurology and Neuropsychiatry):789-805. PubMed ID: 26039855
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of HPA-axis function in posttraumatic stress disorder: pharmacological and non-pharmacological challenge tests, a review.
    de Kloet CS; Vermetten E; Geuze E; Kavelaars A; Heijnen CJ; Westenberg HG
    J Psychiatr Res; 2006 Sep; 40(6):550-67. PubMed ID: 16214171
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Post-traumatic stress disorder in women: current concepts and treatments.
    Butterfield MI; Becker M; Marx CE
    Curr Psychiatry Rep; 2002 Dec; 4(6):474-86. PubMed ID: 12441028
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of brief exercise cessation on pain, fatigue, and mood symptom development in healthy, fit individuals.
    Glass JM; Lyden AK; Petzke F; Stein P; Whalen G; Ambrose K; Chrousos G; Clauw DJ
    J Psychosom Res; 2004 Oct; 57(4):391-8. PubMed ID: 15518675
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Post-traumatic stress disorder: a fast track to premature cardiovascular disease?
    Wentworth BA; Stein MB; Redwine LS; Xue Y; Taub PR; Clopton P; Nayak KR; Maisel AS
    Cardiol Rev; 2013; 21(1):16-22. PubMed ID: 22717656
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dexamethasone suppression test in borderline personality disorder: impact of PTSD symptoms.
    Wingenfeld K; Hill A; Adam B; Driessen M
    Psychiatry Clin Neurosci; 2007 Dec; 61(6):681-3. PubMed ID: 18081632
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treating acute stress disorder and posttraumatic stress disorder with cognitive behavioral therapy or structured writing therapy: a randomized controlled trial.
    van Emmerik AA; Kamphuis JH; Emmelkamp PM
    Psychother Psychosom; 2008; 77(2):93-100. PubMed ID: 18230942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Posttraumatic stress disorder Part III: health effects of interpersonal violence among women.
    Hegadoren KM; Lasiuk GC; Coupland NJ
    Perspect Psychiatr Care; 2006 Aug; 42(3):163-73. PubMed ID: 16916419
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The cross-cultural validity of posttraumatic stress disorder: implications for DSM-5.
    Hinton DE; Lewis-Fernández R
    Depress Anxiety; 2011 Sep; 28(9):783-801. PubMed ID: 21910185
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Instability of physical anxiety symptoms in daily life of patients with panic disorder and patients with posttraumatic stress disorder.
    Pfaltz MC; Michael T; Grossman P; Margraf J; Wilhelm FH
    J Anxiety Disord; 2010 Oct; 24(7):792-8. PubMed ID: 20580527
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dysfunction of stress responsive systems as a risk factor for functional somatic syndromes.
    Tak LM; Rosmalen JG
    J Psychosom Res; 2010 May; 68(5):461-8. PubMed ID: 20403505
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospective evaluation of plasma cortisol in recent trauma survivors with posttraumatic stress disorder.
    Bonne O; Brandes D; Segman R; Pitman RK; Yehuda R; Shalev AY
    Psychiatry Res; 2003 Jul; 119(1-2):171-5. PubMed ID: 12860372
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PTSD treatment in light of DSM-5 and the "golden hours" concept.
    Carmi L; Fostick L; Burshtein S; Cwikel-Hamzany S; Zohar J
    CNS Spectr; 2016 Aug; 21(4):279-82. PubMed ID: 27405848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.